Mitolyns' recent recession from the market has sent ripples throughout the field. Its consequences on both consumers and opponents are still emerging, but initial indications suggest a period of significant transformation. The long-term prospect remains murky, pending further developments in the market. *Analysts{ speculate that Mitolyns' departur